     |
 |
Latest Personal Injury News Anti-Depressants Linked to Suicidal Behavior
Source:
October 15, 2004
Washington: After a September 2004 Food and Drug Administration advisory committee examined the studies and risks, the FDA has announced that anti-depressant packaging will be required to possess a "black box" warning, the strongest safety alert from the government. The label warns patients and their families of the anti-depressants' link to increased suicidal thoughts and behavior among children and teens taking them. The anti-depressant group of drugs to carry this "black box" warning label include: Anafranil, Aventyl, Celexa, Cymbalta, Desyrel, Effexor, Elavil, Lexapro, Ludiomil, Luvox, Marplan, Nardil, Norpramin, Pamelor, Parnate, Paxil, Pexeva, Prozac, Remeron, Sarafem, Serzone, Sinequan, Surmontil, Symbyax,Tofranil, Tofranil-PM, Triavil, Vivactil, Wellbutrin, Zoloft and Zyban. In addition, an information guide will be distributed with each of these anti-depressant prescriptions. Parents of young patients will be advised to monitor warning signs in children like depression; hostility; talking about feeling suicidal or wanting to die; feeling hopeless, like nothing will ever change or get better; feeling helpless, that nothing one does makes any difference; irritability; and strange changes in behavior. << Back to News |